Atea Pharmaceuticals is trading 6.4% up today at $4.92 as shares extend a rebound from a recent sell-off amid a broader market rally.
- The stock is recovering from a July 28 decline that occurred without company-specific news, previously attributed to short-term trading and weak sector sentiment.
- Shares are benefiting from a strong risk-on tone across Wall Street, with major U.S. indices rising more than 1% and lifting beaten-down biotech names.